Miki Nakajima
- Pharmacology top 0.01%
- Molecular Biology top 1%
- Oncology top 0.5%
- Cancer Research top 0.5%
- Pharmacology top 0.5%
- Co-authors
- Tsuyoshi YokoiTatsuki FukamiYuki TsuchiyaMiki KatohShingo TakagiHiroyuki YamanakaHiroshi YamazakiRyoichi Fujiwara
- Topics
- Pharmacogenetics and Drug Metabolism (122 papers)Drug Transport and Resistance Mechanisms (69 papers)Drug-Induced Hepatotoxicity and Protection (51 papers)
- Cited by
- PharmacologyCancer ResearchOncology
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Miki Nakajima
263 papers receiving 10.8k citations
Peers
Comparison fields: 5 of 149
- Pharmacology 4.7k
- Molecular Biology 4.5k
- Oncology 3.0k
- Cancer Research 2.0k
- Pharmacology 1.1k
Countries citing papers authored by Miki Nakajima
This map shows the geographic impact of Miki Nakajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miki Nakajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miki Nakajima more than expected).
Fields of papers citing papers by Miki Nakajima
This network shows the impact of papers produced by Miki Nakajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miki Nakajima. The network helps show where Miki Nakajima may publish in the future.
Co-authorship network of co-authors of Miki Nakajima
This figure shows the co-authorship network connecting the top 25 collaborators of Miki Nakajima. A scholar is included among the top collaborators of Miki Nakajima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miki Nakajima. Miki Nakajima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 5 | |
| 4 | 3 | |
| 5 | 2 | |
| 6 | 3 | |
| 7 | 5 | |
| 8 | 4 | |
| 9 | 3 | |
| 10 | 18 | |
| 11 | 6 | |
| 12 | 13 | |
| 13 | Toxicological evaluation of acyl glucuronides utilizing half-lives, peptide adducts, and immunostimulation assays | 8 |
| 14 | 5 | |
| 15 | 23 | |
| 16 | 35 | |
| 17 | 26 | |
| 18 | 35 | |
| 19 | 87 | |
| 20 | 60 |
About Miki Nakajima
Miki Nakajima is a scholar working on Pharmacology, Cancer Research and Oncology, having authored 267 papers that have together received 11.0k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (122 papers), Drug Transport and Resistance Mechanisms (69 papers) and Drug-Induced Hepatotoxicity and Protection (51 papers). The work is most often cited by research in Pharmacology (4.7k citations), Cancer Research (2.0k citations) and Oncology (3.0k citations). Miki Nakajima has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Tsuyoshi Yokoi, Tatsuki Fukami, Yuki Tsuchiya, Miki Katoh, Shingo Takagi, Hiroyuki Yamanaka, Hiroshi Yamazaki, Ryoichi Fujiwara, Masataka Nakano and Shingo Oda. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.